ID

35267

Beschreibung

ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) Infection; ODM derived from: https://clinicaltrials.gov/show/NCT02517515

Link

https://clinicaltrials.gov/show/NCT02517515

Stichworte

Versionen (1)
  1. 25.02.19 25.02.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

25. Februar 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Chronic Hepatitis C Virus NCT02517515

Englisch

Eligibility Chronic Hepatitis C Virus NCT02517515

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. chinese, south korean, and taiwanese descent with full chinese, south korean, and taiwanese parentage
Beschreibung

Chinese | Born in South Korea | Taiwanese

Datentyp

boolean

Alias
UMLS CUI [1]
C0152035
UMLS CUI [2]
C1277434
UMLS CUI [3]
C1556096
2. chronic hcv-infection prior to study enrollment.
Beschreibung

Hepatitis C, Chronic

Datentyp

boolean

Alias
UMLS CUI [1]
C0524910
3. screening laboratory result indicating hcv gt 1b infection.
Beschreibung

Hepatitis C Genotype

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019196
UMLS CUI [1,2]
C0017431
4. per local standard practice, documented results of one of the following:
Beschreibung

Result

Datentyp

boolean

Alias
UMLS CUI [1]
C1274040
liver biopsy within 24 months prior to or during screening demonstrating the absence of cirrhosis, e.g., a metavir score of ≤ 3 or an ishak score of ≤ 4; or
Beschreibung

Liver Cirrhosis Absent Biopsy of liver | Metavir score f4 | Ishak Score

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0023890
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0193388
UMLS CUI [2]
C4481041
UMLS CUI [3]
C2986945
a screening fibrotest score of ≤ 0.72 and aspartate aminotransferase to platelet ratio index (apri) ≤ 2; or
Beschreibung

FibroTest Score Measurement | AST to platelet ratio index

Datentyp

boolean

Alias
UMLS CUI [1]
C3642160
UMLS CUI [2]
C4483916
a screening fibroscan result of < 9.6 kpa. (participants with a non-qualifying fibrotest/apri or fibroscan result may only be enrolled if they have a qualifying liver biopsy performed within 24 months prior to or during screening.)
Beschreibung

Fibroscan

Datentyp

boolean

Alias
UMLS CUI [1]
C4522043
5. participant has never received antiviral treatment (including ifn-based therapy [ifn (alpha, beta or pegifn) with or without rbv]) for hepatitis c infection (treatment-naïve participant) or participant must have documentation that they met the definition of one of the following categories (treatment experienced participant):
Beschreibung

Antiviral Therapy Absent Hepatitis C | Interferon Absent | Interferon-alpha Absent | Interferon-beta Absent | PEGINTERFERON Absent | Absence Interferon With Ribavirin

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0280274
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0019196
UMLS CUI [2,1]
C3652465
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0002199
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0015980
UMLS CUI [4,2]
C0332197
UMLS CUI [5,1]
C0982327
UMLS CUI [5,2]
C0332197
UMLS CUI [6,1]
C0332197
UMLS CUI [6,2]
C3652465
UMLS CUI [6,3]
C0332287
UMLS CUI [6,4]
C0035525
non-responder or relapser
Beschreibung

Therapy non-responder | Recurrent disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0919875
UMLS CUI [2]
C0277556
6. participant has plasma hcv rna level > 10,000 iu/ml at screening.
Beschreibung

Plasma Hepatitis C virus RNA Level

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0032105
UMLS CUI [1,2]
C0369335
UMLS CUI [1,3]
C0441889
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. hcv genotype performed during screening indicating unable to genotype or infection with any other hcv genotype.
Beschreibung

Hepatitis C virus genotype determination

Datentyp

boolean

Alias
UMLS CUI [1]
C1533728
2. positive test result at screening for hepatitis b surface antigen (hbsag), or hbv-dna > lower limit of quantification (lloq) if hbsag negative, or anti-human immunodeficiency virus antibody (hiv ab).
Beschreibung

Hepatitis B surface antigen positive | Hbv DNA Test | HIV Antibody Measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0149709
UMLS CUI [2]
C1256114
UMLS CUI [3]
C3714540
3. any current or past clinical evidence of cirrhosis such as ascites or esophageal varices, or prior biopsy showing cirrhosis, e.g., a metavir score of > 3 or ishak score of > 4.
Beschreibung

Liver Cirrhosis | Ascites | Esophageal Varices | Liver Cirrhosis Biopsy Previous | Metavir score f4 | Ishak Score

Datentyp

boolean

Alias
UMLS CUI [1]
C0023890
UMLS CUI [2]
C0003962
UMLS CUI [3]
C0014867
UMLS CUI [4,1]
C0023890
UMLS CUI [4,2]
C0005558
UMLS CUI [4,3]
C0205156
UMLS CUI [5]
C4481041
UMLS CUI [6]
C2986945
4. any primary cause of liver disease other than chronic hcv infection, including but not limited to the following:
Beschreibung

Cause Primary Liver disease | Exception Chronic Hepatitis C

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0015127
UMLS CUI [1,2]
C0205225
UMLS CUI [1,3]
C0023895
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0524910
hemochromatosis
Beschreibung

Hemochromatosis

Datentyp

boolean

Alias
UMLS CUI [1]
C0018995
alpha-1 antitrypsin deficiency
Beschreibung

alpha 1-Antitrypsin Deficiency

Datentyp

boolean

Alias
UMLS CUI [1]
C0221757
wilson's disease
Beschreibung

Hepatolenticular Degeneration

Datentyp

boolean

Alias
UMLS CUI [1]
C0019202
autoimmune hepatitis
Beschreibung

Hepatitis, Autoimmune

Datentyp

boolean

Alias
UMLS CUI [1]
C0241910
alcoholic liver disease
Beschreibung

Alcoholic Liver Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0023896
drug-related liver disease steatosis and steatohepatitis on a liver biopsy coincident with hcv-related changes would not be considered exclusionary unless the steatohepatitis is considered to be the primary cause of the liver disease.
Beschreibung

Drug-Induced Liver Disease | Fatty degeneration | Steatohepatitis

Datentyp

boolean

Alias
UMLS CUI [1]
C0860207
UMLS CUI [2]
C0152254
UMLS CUI [3]
C2711227
5. screening laboratory analyses showing abnormal kidney, hepatic, or hematologic function.
Beschreibung

Abnormal renal function | Liver Dysfunction | Hematologic function Abnormal

Datentyp

boolean

Alias
UMLS CUI [1]
C0151746
UMLS CUI [2]
C0086565
UMLS CUI [3,1]
C0221130
UMLS CUI [3,2]
C0205161
6. use of known strong inducers of cytochrome p450 3a (cyp3a) or strong inhibitors of cyp2c8 within 2 weeks or within 10 half-lives, whichever is longer, of the respective medication/supplement prior to study drug administration.
Beschreibung

CYP3A Inducers | CYP2C8 Inhibitors

Datentyp

boolean

Alias
UMLS CUI [1]
C3850044
UMLS CUI [2]
C3850061
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Chronic Hepatitis C Virus NCT02517515

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Chinese | Born in South Korea | Taiwanese
Item
1. chinese, south korean, and taiwanese descent with full chinese, south korean, and taiwanese parentage
boolean
C0152035 (UMLS CUI [1])
C1277434 (UMLS CUI [2])
C1556096 (UMLS CUI [3])
Hepatitis C, Chronic
Item
2. chronic hcv-infection prior to study enrollment.
boolean
C0524910 (UMLS CUI [1])
Hepatitis C Genotype
Item
3. screening laboratory result indicating hcv gt 1b infection.
boolean
C0019196 (UMLS CUI [1,1])
C0017431 (UMLS CUI [1,2])
Result
Item
4. per local standard practice, documented results of one of the following:
boolean
C1274040 (UMLS CUI [1])
Liver Cirrhosis Absent Biopsy of liver | Metavir score f4 | Ishak Score
Item
liver biopsy within 24 months prior to or during screening demonstrating the absence of cirrhosis, e.g., a metavir score of ≤ 3 or an ishak score of ≤ 4; or
boolean
C0023890 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0193388 (UMLS CUI [1,3])
C4481041 (UMLS CUI [2])
C2986945 (UMLS CUI [3])
FibroTest Score Measurement | AST to platelet ratio index
Item
a screening fibrotest score of ≤ 0.72 and aspartate aminotransferase to platelet ratio index (apri) ≤ 2; or
boolean
C3642160 (UMLS CUI [1])
C4483916 (UMLS CUI [2])
Fibroscan
Item
a screening fibroscan result of < 9.6 kpa. (participants with a non-qualifying fibrotest/apri or fibroscan result may only be enrolled if they have a qualifying liver biopsy performed within 24 months prior to or during screening.)
boolean
C4522043 (UMLS CUI [1])
Antiviral Therapy Absent Hepatitis C | Interferon Absent | Interferon-alpha Absent | Interferon-beta Absent | PEGINTERFERON Absent | Absence Interferon With Ribavirin
Item
5. participant has never received antiviral treatment (including ifn-based therapy [ifn (alpha, beta or pegifn) with or without rbv]) for hepatitis c infection (treatment-naïve participant) or participant must have documentation that they met the definition of one of the following categories (treatment experienced participant):
boolean
C0280274 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0019196 (UMLS CUI [1,3])
C3652465 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0002199 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0015980 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0982327 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
C0332197 (UMLS CUI [6,1])
C3652465 (UMLS CUI [6,2])
C0332287 (UMLS CUI [6,3])
C0035525 (UMLS CUI [6,4])
Therapy non-responder | Recurrent disease
Item
non-responder or relapser
boolean
C0919875 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
Plasma Hepatitis C virus RNA Level
Item
6. participant has plasma hcv rna level > 10,000 iu/ml at screening.
boolean
C0032105 (UMLS CUI [1,1])
C0369335 (UMLS CUI [1,2])
C0441889 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Hepatitis C virus genotype determination
Item
1. hcv genotype performed during screening indicating unable to genotype or infection with any other hcv genotype.
boolean
C1533728 (UMLS CUI [1])
Hepatitis B surface antigen positive | Hbv DNA Test | HIV Antibody Measurement
Item
2. positive test result at screening for hepatitis b surface antigen (hbsag), or hbv-dna > lower limit of quantification (lloq) if hbsag negative, or anti-human immunodeficiency virus antibody (hiv ab).
boolean
C0149709 (UMLS CUI [1])
C1256114 (UMLS CUI [2])
C3714540 (UMLS CUI [3])
Liver Cirrhosis | Ascites | Esophageal Varices | Liver Cirrhosis Biopsy Previous | Metavir score f4 | Ishak Score
Item
3. any current or past clinical evidence of cirrhosis such as ascites or esophageal varices, or prior biopsy showing cirrhosis, e.g., a metavir score of > 3 or ishak score of > 4.
boolean
C0023890 (UMLS CUI [1])
C0003962 (UMLS CUI [2])
C0014867 (UMLS CUI [3])
C0023890 (UMLS CUI [4,1])
C0005558 (UMLS CUI [4,2])
C0205156 (UMLS CUI [4,3])
C4481041 (UMLS CUI [5])
C2986945 (UMLS CUI [6])
Cause Primary Liver disease | Exception Chronic Hepatitis C
Item
4. any primary cause of liver disease other than chronic hcv infection, including but not limited to the following:
boolean
C0015127 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C0023895 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0524910 (UMLS CUI [2,2])
Hemochromatosis
Item
hemochromatosis
boolean
C0018995 (UMLS CUI [1])
alpha 1-Antitrypsin Deficiency
Item
alpha-1 antitrypsin deficiency
boolean
C0221757 (UMLS CUI [1])
Hepatolenticular Degeneration
Item
wilson's disease
boolean
C0019202 (UMLS CUI [1])
Hepatitis, Autoimmune
Item
autoimmune hepatitis
boolean
C0241910 (UMLS CUI [1])
Alcoholic Liver Disease
Item
alcoholic liver disease
boolean
C0023896 (UMLS CUI [1])
Drug-Induced Liver Disease | Fatty degeneration | Steatohepatitis
Item
drug-related liver disease steatosis and steatohepatitis on a liver biopsy coincident with hcv-related changes would not be considered exclusionary unless the steatohepatitis is considered to be the primary cause of the liver disease.
boolean
C0860207 (UMLS CUI [1])
C0152254 (UMLS CUI [2])
C2711227 (UMLS CUI [3])
Abnormal renal function | Liver Dysfunction | Hematologic function Abnormal
Item
5. screening laboratory analyses showing abnormal kidney, hepatic, or hematologic function.
boolean
C0151746 (UMLS CUI [1])
C0086565 (UMLS CUI [2])
C0221130 (UMLS CUI [3,1])
C0205161 (UMLS CUI [3,2])
CYP3A Inducers | CYP2C8 Inhibitors
Item
6. use of known strong inducers of cytochrome p450 3a (cyp3a) or strong inhibitors of cyp2c8 within 2 weeks or within 10 half-lives, whichever is longer, of the respective medication/supplement prior to study drug administration.
boolean
C3850044 (UMLS CUI [1])
C3850061 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video